Nicolet Advisory Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$727K Buy
3,915
+1,112
+40% +$182K 0.05% 180
2025
Q3
$427K Sell
2,803
-35
-1% -$4.73K 0.03% 249
2025
Q2
$374K Buy
2,838
+430
+18% +$53.6K 0.03% 261
2025
Q1
$273K Buy
+2,408
New +$344K 0.03% 301
2024
Q4
Sell
-1,848
Closed -$341K 381
2024
Q3
$341K Buy
1,848
+19
+1% +$3.98K 0.03% 263
2024
Q2
$426K Buy
1,829
+246
+16% +$53.5K 0.04% 225
2024
Q1
$327K Buy
1,583
+102
+7% +$23.9K 0.03% 253
2023
Q4
$382K Sell
1,481
-449
-23% -$110K 0.04% 204
2023
Q3
$496K Buy
1,930
+541
+39% +$145K 0.06% 158
2023
Q2
$396K Buy
1,389
+55
+4% +$16.4K 0.04% 186
2023
Q1
$383K Buy
1,334
+181
+16% +$50.1K 0.04% 180
2022
Q4
$329K Buy
+1,153
New +$326K 0.04% 176

Other funds holding BIIB

Nicolet Advisory Services's BIIB Position: Q4 2025 in Review

Nicolet Advisory Services increased its Biogen (BIIB) stake by 40% in Q4 2025, buying an estimated $182K and bringing the position to 3,915 shares worth $727K. The position accounts for 0.05% of the portfolio, ranked #180.

Nicolet Advisory Services first reported a position in BIIB in Q4 2022 and has held it in 12 quarters since. 997 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.

  • Nicolet Advisory Services held 3,915 shares of Biogen worth $727K as of Q4 2025.
  • Nicolet Advisory Services bought 1,112 Biogen shares in Q4 2025, an estimated $182K.
  • Biogen made up 0.05% of Nicolet Advisory Services's portfolio in Q4 2025, its #180 holding.
  • Nicolet Advisory Services first reported a position in Biogen in Q4 2022 and has held it in 12 quarters since.
  • 997 funds tracked by Wall St. Rank held Biogen as of Q4 2025.

Based on Nicolet Advisory Services's 13F filing for Q4 2025, filed 13 Feb 2026.